Tae Hyun Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tae Hyun Lee has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Christopher D. Roberts
Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, WI 53705, USA
1 shared publication - Doug R. Braun
Pharmaceutical Sciences Division, University of Wisconsin–Madison, Madison, WI 53705, USA
1 shared publication - Imraan Alas
Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, WI 53705, USA
1 shared publication - Nathaniel J. Brittin
Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, WI 53705, USA
1 shared publication - Scott R. Rajski
Pharmaceutical Sciences Division, University of Wisconsin–Madison, Madison, WI 53705, USA
1 shared publication - Shaurya Chanana
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, WI 53705, USA
1 shared publication
Latest Publications
- Open Access
- 31 July 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (8) , 316
Discovery of New Everninomicin Analogs from a Marine-Derived Micromonospora sp. by Metabolomics and Genomics Approaches
During the course of genome mining initiatives, we identified a marine-derived Micromonospora, assigned here as strain WMMD956; the genome of WMMD956 appeared to contain a number of features associated with everninomicins, well-known antimicrobial orthosomycins. In addition, LCMS-based hierarchical clustering analysis and principal component analysis (hcapca) revealed that WMMD956 displayed an extreme degree of metabolomic and genomic novelty. Dereplication of high-resolution tandem mass spectrometry (HRMS/MS) and Global Natural Product Social molecular networking platform (GNPS) analysis of WMMD956 resulted in the identification of several analogs of the previously known everninomicin. Chemical structures were unambiguously confirmed by HR-ESI-MS, 1D and 2D NMR experiments, and the use of MS/MS data. The isolated metabolites, 1–3, were evaluated for their antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
- 31 July 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (8) , 316
Open AccessDiscovery of New Everninomicin Analogs from a Marine-Derived Micromonospora sp. by Metabolomics and Genomics Approaches
During the course of genome mining initiatives, we identified a marine-derived Micromonospora, assigned here as strain WMMD956; the genome of WMMD956 appeared to contain a number of features associated with everninomicins, well-known antimicrobial orthosomycins. In addition, LCMS-based hierarchical clustering analysis and principal component analysis (hcapca) revealed that WMMD956 displayed an extreme degree of metabolomic and genomic novelty. Dereplication of high-resolution tandem mass spectrometry (HRMS/MS) and Global Natural Product Social molecular networking platform (GNPS) analysis of WMMD956 resulted in the identification of several analogs of the previously known everninomicin. Chemical structures were unambiguously confirmed by HR-ESI-MS, 1D and 2D NMR experiments, and the use of MS/MS data. The isolated metabolites, 1–3, were evaluated for their antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).